Beom-Jun Kim
6PUBLICATIONS
112CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Aug 08, 2025
Integrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast Cancer.Nicholas J Neill, Shankha Satpathy, Karsten Krug
|May 23, 2024
PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast Cancer.Anran Chen, Beom-Jun Kim, Aparna Mitra
|Aug 17, 2023
Kinase Inhibitor Pulldown Assay Identifies a Chemotherapy Response Signature in Triple-negative Breast Cancer Based on Purine-binding Proteins.Junkai Wang, Alexander B Saltzman, Eric J Jaehnig
|Jul 28, 2023
Proteogenomic Approaches for the Identification of NF1/Neurofibromin-depleted Estrogen Receptor-positive Breast Cancers for Targeted Treatment.Beom-Jun Kim, Ze-Yi Zheng, Jonathan T Lei
|Apr 18, 2023
Kinome Reprogramming Is a Targetable Vulnerability in ESR1 Fusion-Driven Breast Cancer.Xuxu Gou, Beom-Jun Kim, Meenakshi Anurag
|Aug 24, 2022
Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer.Meenakshi Anurag, Eric J Jaehnig, Karsten Krug
Pageof 1
Frequent Collaborators
6 joint publications
Meenakshi Anurag
6 joint publications
Matthew J Ellis
5 joint publications
Jonathan T Lei
4 joint publications
Matthew V Holt
3 joint publications
George Miles
3 joint publications
Bing Zhang
3 joint publications
Diana Fandino
3 joint publications
Michael T Lewis
3 joint publications
Xuxu Gou
3 joint publications
Lacey E Dobrolecki
